The ongoing HIVEC HEAT trial aims to generate clinical data to evidence the efficacy of hyperthermic intravesical 80mg mitomycin C chemotherapy for patients with BCG-unresponsive, high risk NMIBC

Ventris Medical Announces the Award of Additional Patent Claims for its Novel Backpack Bone Graft Containment System
Russell Cook, CEO of Ventris Medical – “This patent validates years of focused R&D and represents a meaningful step forward in solving one of the biggest challenges in bone grafting—maintaining the graft exactly where the surgeon places it














